| 000 | 01235 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514170035.0 | ||
| 264 | 0 | _c20040315 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a1060-0280 | ||
| 024 | 7 |
_a10.1345/aph.1D019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCrowe, Susan M | |
| 245 | 0 | 0 |
_aVardenafil treatment for erectile dysfunction. _h[electronic resource] |
| 260 |
_bThe Annals of pharmacotherapy _cJan 2004 |
||
| 300 |
_a77-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _a3',5'-Cyclic-GMP Phosphodiesterases |
| 650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 5 |
| 650 | 0 | 4 |
_aErectile Dysfunction _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xmetabolism |
| 650 | 0 | 4 | _aPhosphoric Diester Hydrolases |
| 650 | 0 | 4 |
_aPiperazines _xmetabolism |
| 650 | 0 | 4 | _aSulfones |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTriazines |
| 650 | 0 | 4 | _aVardenafil Dihydrochloride |
| 700 | 1 | _aStreetman, Daniel S | |
| 773 | 0 |
_tThe Annals of pharmacotherapy _gvol. 38 _gno. 1 _gp. 77-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1345/aph.1D019 _zAvailable from publisher's website |
| 999 |
_c14467659 _d14467659 |
||